<DOC>
	<DOCNO>NCT00006342</DOCNO>
	<brief_summary>RATIONALE : Determination genetic marker leukemia non-Hodgkin 's lymphoma secondary Hodgkin 's disease childhood brain tumor may help doctor identify patient risk cancer . PURPOSE : Clinical trial determine presence certain gene patient receive treatment Hodgkin 's disease childhood brain tumor .</brief_summary>
	<brief_title>Genetic Study Patients Receiving Treatment Hodgkin 's Disease Childhood Brain Tumor</brief_title>
	<detailed_description>OBJECTIVES : I . Determine frequency chromosome 3 , 11 , 21 aberration peripheral blood lymphocyte ( PBL ) specifically associate acute myelogenous leukemia patient adult pediatric Hodgkin 's disease treat radiotherapy and/or chemotherapy . II . Determine frequency aberration patient pediatric central nervous system tumor treat radiotherapy and/or chemotherapy . III . Determine glutathione-S-transferase allotype , associate human toxicological response carcinogen exposure , patient . IV . Determine frequency ( 14 ; 18 ) gene rearrangement , associate deregulation bcl-2 proto-oncogene non-Hodgkin 's lymphoma , PBL patient . OUTLINE : An extra tube blood collect , every 4 week , every 3 month radiotherapy and/or chemotherapy . DNA isolate blood sample GSTM1 , GSTT1 , various cytochrome P ( CYP ) 450 genotype determine polymerase chain reaction ( PCR ) . Mononuclear leukocytes analyzed chromosome aberration chromosome number 3 , 11 , 21 . Pretreatment karyotype frequency translocation determine patient . Peripheral blood lymphocyte DNA also examine ( 14 ; 18 ) gene rearrangement . PROJECTED ACCRUAL : A total 50 patient accrue study within 2 year .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis Hodgkin 's disease Adult child OR Diagnosis primary central nervous system ( CNS ) malignancy 16 Medulloblastoma Ependymoma Brain stem glioma Astrocytoma Primitive neuroectodermal tumor ( PNET ) Proposed therapy must include external beam radiotherapy and/or chemotherapy PATIENT CHARACTERISTICS : Age : See Disease Characteristics Any age Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : See Disease Characteristics Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>stage I adult Hodgkin lymphoma</keyword>
	<keyword>stage II adult Hodgkin lymphoma</keyword>
	<keyword>stage III adult Hodgkin lymphoma</keyword>
	<keyword>stage IV adult Hodgkin lymphoma</keyword>
	<keyword>recurrent adult Hodgkin lymphoma</keyword>
	<keyword>childhood infratentorial ependymoma</keyword>
	<keyword>childhood low-grade cerebral astrocytoma</keyword>
	<keyword>childhood supratentorial ependymoma</keyword>
	<keyword>stage II childhood Hodgkin lymphoma</keyword>
	<keyword>stage I childhood Hodgkin lymphoma</keyword>
	<keyword>stage III childhood Hodgkin lymphoma</keyword>
	<keyword>stage IV childhood Hodgkin lymphoma</keyword>
	<keyword>recurrent/refractory childhood Hodgkin lymphoma</keyword>
	<keyword>childhood high-grade cerebral astrocytoma</keyword>
	<keyword>untreated childhood brain stem glioma</keyword>
	<keyword>recurrent childhood brain stem glioma</keyword>
	<keyword>untreated childhood supratentorial primitive neuroectodermal tumor</keyword>
	<keyword>recurrent childhood supratentorial primitive neuroectodermal tumor</keyword>
	<keyword>untreated childhood cerebellar astrocytoma</keyword>
	<keyword>recurrent childhood cerebellar astrocytoma</keyword>
	<keyword>recurrent childhood cerebral astrocytoma</keyword>
	<keyword>untreated childhood medulloblastoma</keyword>
	<keyword>recurrent childhood medulloblastoma</keyword>
	<keyword>newly diagnose childhood ependymoma</keyword>
	<keyword>recurrent childhood ependymoma</keyword>
</DOC>